-
RIL, Aurobindo Pharma, Britannia Industries to be watched
Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, to the Government of India at Rs. 265 per dose.
-
Zydus vaccine: Check launch date and other details
Vaccinators are also being trained by Zydus Cadila to administer the vaccine, which is using a needle-free applicator
-
Zydus Cadila’s Covid vaccine to be launched in October: Report
This will be the first vaccine to be administered to the age group of 12 to 18 years in India.
-
Zydus Cadila applies for emergency use authorisation for the Covid-19 vaccine
Zydus Cadila has applied for emergency use authorisation (EUA) with the DCGI for its COVID-19 vaccine ZyCoV-D.
-
Fighting Covid: 10 lakh doses of Virafin coming soon at chemists; may be priced lower than Remdesivir
Unlike Remdesivir, Virafin need not be administered in a hospital setting. It can be given to patients recovering at home. Moreover, it is a single-do
-
Zydus Cadila’s Virafin gets emergency authorisation for COVID-19 treatment
A single-dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients, Zydus Cadila said
-
Good news for cancer and BP patients
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 1
-
Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment
Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name 'PegiHep' has shown promising results in treati
-
Zydus Cadila reduces price of generic COVID-19 drug to Rs 899 per vial
Zydus Cadila had launched Remdac in August 2020 at Rs 2,800 per 100 mg lyophilized injection in the country
